NVO and NOVOB:DC Related Headlines
Go Back- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK990 at Morgan Stanley
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK900 at Berenberg
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK960 at Stifel
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,100 at Deutsche Bank
- Citi Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,050 at Barclays
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK930 at Morgan Stanley
- Deutsche Bank Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK850 at Berenberg
- Deutsche Bank Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK560 at Societe Generale
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK950 at JPMorgan
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK950 at Deutsche Bank
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK900 at Barclays
- UBS Reiterates Neutral Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Citi Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK500 at Jefferies
- UBS Assumes Novo Nordisk (NOVOB:DC) (NVO) at Neutral
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK800 at Morgan Stanley
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK850 at Deutsche Bank
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK465 at Jefferies
- Barclays Reiterates Overweight Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Deutsche Bank Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Barclays Reiterates Overweight Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Deutsche Bank Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK650 at Berenberg
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK850 at JPMorgan
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK800 at Stifel
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK800 at JPMorgan
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK730 at Morgan Stanley
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK430 at Jefferies
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK760 at Stifel
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK750 at DNB Markets
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK825 at Barclays
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK745 at Citi
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK705 at Morgan Stanley
- Citi Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK745 at Stifel
- Deutsche Bank Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK700 at Morgan Stanley
- Barclays Reiterates Overweight Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Jefferies Reiterates Underperform Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Jefferies Reiterates Underperform Rating on Novo Nordisk (NOVOB:DC) (NVO)
- JPMorgan Reiterates Overweight Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK650 at CFRA
- Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK725 at Barclays
- Deutsche Bank Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,620 at BofA Securities
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,500 at JPMorgan
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,220 at Berenberg
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,370 at Morgan Stanley
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,450 at Barclays
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,550 at Deutsche Bank
- HSBC Starts Novo Nordisk (NOVOB:DC) (NVO) at Buy
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,210 at Morgan Stanley
- BofA Securities Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Deutsche Bank Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- UBS Reiterates Sell Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,150 at Berenberg
- BofA Securities Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Deutsche Bank Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK720 at UBS
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,160 at Morgan Stanley